Quoin Pharmaceuticals Ltd - ADR

NASDAQ:QNRX  
3.23
-0.43 (-11.75%)
Products

Quoin Pharma Signs Agreement With AFT Pharma For Its Lead Asset, QRX003

Published: 11/08/2021 14:06 GMT
Quoin Pharmaceuticals Ltd - ADR (QNRX) - Quoin Pharmaceuticals Signs Exclusive Licensing and Distribution Agreement With Aft Pharmaceuticals for Its Lead Asset, Qrx003.
Quoin Pharmaceuticals Ltd - Aft Gains Exclusive Rights to Commercialize Qrx003 in Australia and New Zealand.
Quoin Pharmaceuticals Ltd - Will Be Entitled to a 20% Royalty on Net Sales of Product in Australia and New Zealand.